Parathyroid hormone-related peptide and primary hyperparathyroidism

Mario Testini, Angela Gurrado, Germana Lissidini, Giuseppe Piccinni, Luigi Greco, Francesco Basile, Antonio Biondi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The parathyroid hormone-related peptide (PTHrP) has been shown to be the major pathogenic factor to humoral hypercalcemia of malignancy (HHM). The presence of PTHrP in many normal tissues and in normal or abnormal parathyroids has been described in literature and its role has been investigated. PTHrP release from parathyroid cells into the extracellular space has been demonstrated to depend on the extracellular calcium concentration. The hormone binds to PTH type 1 Receptor (PTH1R) with a high affinity, as well as parathyroid hormone (PTH). These hormones' amino-terminal (1-34) peptide fragments are considered sufficient to achieve efficient receptor activation and action on mineral ion homeostasis. Generally, diagnosis of primary hyperparathyroidism (PHPT) is based on hypercalcaemia and elevated levels of PTH. The advent of intact-PTH immunoradiometric assay allowed us to distinguish PHPT from non-parathyroid-dependent hypercalcaemia, but the presentation of normal PTH level and hypercalcaemia due to a parathyroid adenoma is possible. The aim of the study is to identify the relationship between the production of PTHrP without malignancy and the diagnosis of PHPT by a systematic review.

Original languageEnglish
Pages (from-to)299-312
Number of pages14
JournalFrontiers in Bioscience - Scholar
Volume2 S
Issue number1
Publication statusPublished - Jan 1 2010

Fingerprint

Parathyroid Hormone-Related Protein
Primary Hyperparathyroidism
Parathyroid Hormone
Hypercalcemia
Parathyroid Hormone Receptor Type 1
Hormones
Immunoradiometric Assay
Parathyroid Neoplasms
Peptide Fragments
Extracellular Space
Minerals
Assays
Homeostasis
Chemical activation
Ions
Tissue
Calcium
Neoplasms

Keywords

  • Hypercalcaemia
  • Parathyroid Adenoma
  • Primary Hyperparathyroidism
  • PTH
  • PTHrP
  • Review

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Testini, M., Gurrado, A., Lissidini, G., Piccinni, G., Greco, L., Basile, F., & Biondi, A. (2010). Parathyroid hormone-related peptide and primary hyperparathyroidism. Frontiers in Bioscience - Scholar, 2 S(1), 299-312.

Parathyroid hormone-related peptide and primary hyperparathyroidism. / Testini, Mario; Gurrado, Angela; Lissidini, Germana; Piccinni, Giuseppe; Greco, Luigi; Basile, Francesco; Biondi, Antonio.

In: Frontiers in Bioscience - Scholar, Vol. 2 S, No. 1, 01.01.2010, p. 299-312.

Research output: Contribution to journalArticle

Testini, M, Gurrado, A, Lissidini, G, Piccinni, G, Greco, L, Basile, F & Biondi, A 2010, 'Parathyroid hormone-related peptide and primary hyperparathyroidism', Frontiers in Bioscience - Scholar, vol. 2 S, no. 1, pp. 299-312.
Testini M, Gurrado A, Lissidini G, Piccinni G, Greco L, Basile F et al. Parathyroid hormone-related peptide and primary hyperparathyroidism. Frontiers in Bioscience - Scholar. 2010 Jan 1;2 S(1):299-312.
Testini, Mario ; Gurrado, Angela ; Lissidini, Germana ; Piccinni, Giuseppe ; Greco, Luigi ; Basile, Francesco ; Biondi, Antonio. / Parathyroid hormone-related peptide and primary hyperparathyroidism. In: Frontiers in Bioscience - Scholar. 2010 ; Vol. 2 S, No. 1. pp. 299-312.
@article{5126e11c5bff4f6da5dcde2532d50193,
title = "Parathyroid hormone-related peptide and primary hyperparathyroidism",
abstract = "The parathyroid hormone-related peptide (PTHrP) has been shown to be the major pathogenic factor to humoral hypercalcemia of malignancy (HHM). The presence of PTHrP in many normal tissues and in normal or abnormal parathyroids has been described in literature and its role has been investigated. PTHrP release from parathyroid cells into the extracellular space has been demonstrated to depend on the extracellular calcium concentration. The hormone binds to PTH type 1 Receptor (PTH1R) with a high affinity, as well as parathyroid hormone (PTH). These hormones' amino-terminal (1-34) peptide fragments are considered sufficient to achieve efficient receptor activation and action on mineral ion homeostasis. Generally, diagnosis of primary hyperparathyroidism (PHPT) is based on hypercalcaemia and elevated levels of PTH. The advent of intact-PTH immunoradiometric assay allowed us to distinguish PHPT from non-parathyroid-dependent hypercalcaemia, but the presentation of normal PTH level and hypercalcaemia due to a parathyroid adenoma is possible. The aim of the study is to identify the relationship between the production of PTHrP without malignancy and the diagnosis of PHPT by a systematic review.",
keywords = "Hypercalcaemia, Parathyroid Adenoma, Primary Hyperparathyroidism, PTH, PTHrP, Review",
author = "Mario Testini and Angela Gurrado and Germana Lissidini and Giuseppe Piccinni and Luigi Greco and Francesco Basile and Antonio Biondi",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "2 S",
pages = "299--312",
journal = "Frontiers in Bioscience - Scholar",
issn = "1945-0516",
publisher = "Frontiers in Bioscience",
number = "1",

}

TY - JOUR

T1 - Parathyroid hormone-related peptide and primary hyperparathyroidism

AU - Testini, Mario

AU - Gurrado, Angela

AU - Lissidini, Germana

AU - Piccinni, Giuseppe

AU - Greco, Luigi

AU - Basile, Francesco

AU - Biondi, Antonio

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The parathyroid hormone-related peptide (PTHrP) has been shown to be the major pathogenic factor to humoral hypercalcemia of malignancy (HHM). The presence of PTHrP in many normal tissues and in normal or abnormal parathyroids has been described in literature and its role has been investigated. PTHrP release from parathyroid cells into the extracellular space has been demonstrated to depend on the extracellular calcium concentration. The hormone binds to PTH type 1 Receptor (PTH1R) with a high affinity, as well as parathyroid hormone (PTH). These hormones' amino-terminal (1-34) peptide fragments are considered sufficient to achieve efficient receptor activation and action on mineral ion homeostasis. Generally, diagnosis of primary hyperparathyroidism (PHPT) is based on hypercalcaemia and elevated levels of PTH. The advent of intact-PTH immunoradiometric assay allowed us to distinguish PHPT from non-parathyroid-dependent hypercalcaemia, but the presentation of normal PTH level and hypercalcaemia due to a parathyroid adenoma is possible. The aim of the study is to identify the relationship between the production of PTHrP without malignancy and the diagnosis of PHPT by a systematic review.

AB - The parathyroid hormone-related peptide (PTHrP) has been shown to be the major pathogenic factor to humoral hypercalcemia of malignancy (HHM). The presence of PTHrP in many normal tissues and in normal or abnormal parathyroids has been described in literature and its role has been investigated. PTHrP release from parathyroid cells into the extracellular space has been demonstrated to depend on the extracellular calcium concentration. The hormone binds to PTH type 1 Receptor (PTH1R) with a high affinity, as well as parathyroid hormone (PTH). These hormones' amino-terminal (1-34) peptide fragments are considered sufficient to achieve efficient receptor activation and action on mineral ion homeostasis. Generally, diagnosis of primary hyperparathyroidism (PHPT) is based on hypercalcaemia and elevated levels of PTH. The advent of intact-PTH immunoradiometric assay allowed us to distinguish PHPT from non-parathyroid-dependent hypercalcaemia, but the presentation of normal PTH level and hypercalcaemia due to a parathyroid adenoma is possible. The aim of the study is to identify the relationship between the production of PTHrP without malignancy and the diagnosis of PHPT by a systematic review.

KW - Hypercalcaemia

KW - Parathyroid Adenoma

KW - Primary Hyperparathyroidism

KW - PTH

KW - PTHrP

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=77957301899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957301899&partnerID=8YFLogxK

M3 - Article

VL - 2 S

SP - 299

EP - 312

JO - Frontiers in Bioscience - Scholar

JF - Frontiers in Bioscience - Scholar

SN - 1945-0516

IS - 1

ER -